Inventor · disambiguated record
Shojiro Kadono
Also filed as: KADONO SHOJIRO
18 granted patents·12 pending applications·164 citations·filing 2002–2025
94Inventor score
Top patents by PatentIndex Score
30 records- 0197US11142587B2Method for producing polypeptide hetero-oligomerCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 12, 2021·13 cites·14 claims
- 0296US11718678B2Method for altering plasma retention and immunogenicity of antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 8, 2023·7 cites·16 claims
- 0395US11154615B2Library of antigen-binding molecules including modified antibody variable regionCHUGAI PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 26, 2021·8 cites·11 claims
- 0494US11912989B2Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 27, 2024·3 cites·14 claims
- 0594US11142563B2Antigen-binding molecule containing modified Fc regionCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Oct 12, 2021·18 cites·53 claims
- 0694US10919953B2FcgammaRIIB-specific Fc region variantCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Feb 16, 2021·24 cites·8 claims
- 0794US10618965B2Method for altering plasma retention and immunogenicity of antigen-binding moleculeIGAWA TOMOYUKI·Filed 2012·Granted Apr 14, 2020·32 cites·33 claims
- 0893US11673947B2Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 13, 2023·7 cites·51 claims
- 0993US9890218B2Heterodimerized polypeptideMIMOTO FUTA·Filed 2012·Granted Feb 13, 2018·32 cites·39 claims
- 1092US11739149B2Antigen-binding molecule containing modified antibody variable regionCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Aug 29, 2023·5 cites·18 claims
- 1191US12234573B2Library of antigen-binding molecules including modified antibody variable regionCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 25, 2025·1 cites·12 claims
- 1289US10961530B2Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Mar 30, 2021·6 cites·21 claims
- 1385US12479916B2Antigen-binding molecule containing modified antibody variable regionCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Nov 25, 2025·0 cites·19 claims
- 1483US12304960B2Anti-CD137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted May 20, 2025·3 cites·27 claims
- 1579US12371511B2Heterodimerized polypeptideCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 29, 2025·1 cites·29 claims
- 1678US2023174655A1Fc-gamma-RIIb-SPECIFIC Fc ANTIBODYCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1778US2023279099A1Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1878US2024158785A1Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1972US12359001B2Method for producing polypeptide hetero-oligomerCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Jul 15, 2025·0 cites·24 claims
- 2069US2025154689A1Library of Antigen-Binding Molecules Including Modified Antibody Variable RegionCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 2168US2023140797A1ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA Fc GAMMA RIIBCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2262US2016280787A1Antigen-binding molecule containing modified antibody variable regionCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 2362US2025388689A1Anti-cd137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 2461US2021261648A1FCgammaRIIB-SPECIFIC FC REGION VARIANTCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2561US2023257470A1Method for altering plasma retention and immunogenicity of antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 2658US7001887B2Peptide derivativesCHUGAI PHARMACEUTICAL CO LTD·Filed 2002·Granted Feb 21, 2006·4 cites·13 claims
- 2756US2014093496A1Fc-gamma-RIIb-SPECIFIC Fc ANTIBODYMIMOTO FUTA·Filed 2012·Application pending·0 cites
- 2853US2015166654A1Target tissue-specific antigen-binding moleculeCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 2951US7879887B2α-amino acid derivatives and medicaments containing the same as an active ingredientNISSAN CHEMICAL IND LTD·Filed 2007·Granted Feb 1, 2011·0 cites·14 claims
- 3049US2016046693A1Antigen-Binding Molecule for Promoting Disappearance of Antigen via Fc gamma RIIBCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shojiro Kadono files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →